Stock BGNE BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 01:30:00 20/09/2024 am IST 		5-day change 1st Jan Change
198.59 USD +0.66% Intraday chart for BeiGene, Ltd. +1.18% +10.11%
18/09 JMP Securities Initiates BeiGene at Outperform With $288 Price Target MT
17/09 BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma After Prior Chemotherapy CI

Chart calendar BeiGene, Ltd.

4ed44e0c13975eb9aca6d8a58.OGtXixy24z7UaBoumI2O_cXno6Evk_TJOH53PLmPFAM.Vggw-HLGiFySGG9Fx8v9rovWkskYyrqECS4cRe7fVTFBESP9bISBUJ8iTw~7d5b426c60f35a3becdca9b6e250e57e

Upcoming events on BeiGene, Ltd.

07/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
01/05/2025 Q1 2025 Earnings Release (Projected)
22/08/2025 Q2 2025 Earnings Release (Projected)

Past events on BeiGene, Ltd.

05/09/2024 07:30 pm Morgan Stanley Healthcare Conference - Fireside Chat
27/08/2024 Q2 2024 Earnings Release
07/08/2024 Q2 2024 Earnings Call
13/06/2024 European Hematology Association Meeting - Abstract No - P1124
13/06/2024 European Hematology Association Meeting - Abstract No - P538
13/06/2024 European Hematology Association Meeting - Abstract No - PB2546
13/06/2024 European Hematology Association Meeting - Abstract No - P698
13/06/2024 European Hematology Association Meeting - Abstract No - P562
13/06/2024 European Hematology Association Meeting - Abstract No - P697
13/06/2024 European Hematology Association Meeting - Abstract No - P898
13/06/2024 European Hematology Association Meeting - Abstract No - PB2540
13/06/2024 European Hematology Association Meeting - Abstract No - P685
13/06/2024 European Hematology Association Meeting - Abstract No - P1834
13/06/2024 European Hematology Association Meeting - Abstract No - P2045
13/06/2024 European Hematology Association Meeting - Abstract No - P1143
13/06/2024 European Hematology Association Meeting - Abstract No - P1836
13/06/2024 European Hematology Association Meeting - Abstract No - PB2954
13/06/2024 European Hematology Association Meeting - Abstract No - P702
13/06/2024 European Hematology Association Meeting - Abstract No - P700
13/06/2024 European Hematology Association Meeting - Abstract No - P1123

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD		Released
Forecast
Spread 		1 176
1 198
-1.84%		1 416
1 420
-0.32%		2 459
2 414
1.87%
3 616


4 534


5 595

EBITDA
Million USD		Released
Forecast
Spread 		-1 392
-1 201
-15.88%		-1 723
-1 678
-2.69%		-1 120
-1 105
-1.38%
-588


-93,2


440

EBIT
Million USD		Released
Forecast
Spread 		-1 439
-1 239
-16.11%		-1 790
-1 751
-2.23%		-1 208
-1 161
-3.99%
-702


-224


288

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-1 439
-1 253
-14.77%		-1 961
-1 853
-5.82%		-826
-903
8.51%
-662


-199


403

Net income
Million USD		Released
Forecast
Spread 		-1 413
-1 223
-15.55%		-2 004
-1 832
-9.4%		-882
-911
3.23%
-674


-161


368

EPS
USD		Released
Forecast
Spread 		-15,2
-10,0
-52.22%		-19,4
-15,0
-29.66%		-8,45
-8,56
1.3%
-5,98


-0,93


4,63

Announcement Date25/02/2227/02/2326/02/24-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2
Net sales
Million USD		Released
Forecast
Spread 		388
377
2.7%		380
388
-2.08%		606
723
-16.13%		448
449
-0.36%		595
515
15.5%		1 043
946
10.32%		781
578
35.12%		634
638
-0.61%		752
675
11.32%		929
809
14.83%		1 681
1 604
4.79%
981


1 035


1 948


1 058


1 105


1 159


1 208


1 241


1 267

EBITDA
Million USD		Released
Forecast
Spread 		-422
-355
-18.83%		-451
-442
-1.91%


-351
-346
-1.55%





-112
-232
51.55%		-565
-304
-86.18%		-236
-406
41.89%		-82,2
-293
71.94%



-282


-245





-93,5


-74,5


-60,2


-57,9


74,2


100

EBIT
Million USD		Released
Forecast
Spread 		-438
-391
-12.08%		-469
-472
0.67%		-907
-1 086
16.48%		-371
-373
0.58%		-319
-393
18.97%		-690
-781
11.66%		-134
-345
61.22%		-589
-364
-61.67%		-261
-376
30.56%		-107
-253
57.69%		-369
-455
19.01%
-157


-135


-190


-90,6


-55,1


-18,2


-5,65


27,1


53,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-551
-377
-46.08%		-431
-457
5.77%		-982
-1 075
8.63%		-337
-374
10.01%		-367
-379
3.17%		-704
-729
3.37%		229
-365
162.87%		-351
-441
20.54%		-243
-309
21.23%		-106
-219
51.6%		-349
-422
17.22%
-85,4


-62,2


-161


-55,8


-11,9


36,5


54,3







Net income
Million USD		Released
Forecast
Spread 		-558
-396
-40.84%		-445
-456
2.24%		-998
-1 105
9.67%		-348
-403
13.62%		-381
-381
0.04%		-730
-752
2.92%		215
-376
157.31%		-368
-431
14.81%		-251
-302
16.88%		-120
-236
49.04%		-372
-438
15.17%
-101


-75,4


-166


-58,6


-12,6


28,8


42,9







EPS
USD		Released
Forecast
Spread 		-5,39
-3,85
-40.04%		-4,29
-4,19
-2.47%


-3,34
-3,82
12.45%		-3,64
-3,53
-2.98%


2,01
-3,28
161.25%		-3,48
-4,03
13.68%		-2,41
-2,45
1.53%		-1,15
-2,38
51.74%



-1,09


-0,75





-0,64


0,06


0,24


0,69







Announcement Date09/11/2227/02/2327/02/2304/05/2302/08/2302/08/2309/11/2326/02/2408/05/2407/08/2407/08/24---------

Upcoming sector events for BeiGene, Ltd.

25/09/2024 PHILOGEN S.P.A.: Q2 2024 Earnings Release
10/10/2024 NURIX THERAPEUTICS, INC.: Q3 2024 Earnings Release (Projected)
10/10/2024 10:30 am KUROS BIOSCIENCES AG: Q3 2024 Sales and Revenue Release - Trading Update
22/10/2024 IDORSIA LTD: Q3 2024 Earnings Release (Projected)
24/10/2024 REMEGEN CO., LTD.: Q3 2024 Earnings Release (Projected)
24/10/2024 PTC THERAPEUTICS, INC.: Q3 2024 Earnings Release (Projected)
24/10/2024 INSMED INCORPORATED: Q3 2024 Earnings Release (Projected)
24/10/2024 BIOCON LIMITED: Q2 2025 Earnings Release (Projected)
24/10/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q3 2024 Earnings Release (Projected)
24/10/2024 BIO-THERA SOLUTIONS, LTD.: Q3 2024 Earnings Release (Projected)
More events

Past sector events for BeiGene, Ltd.

05/09/2024 01:50 pm PHARMAESSENTIA CORPORATION: August 2024 Sales and Revenue Release
04/09/2024 01:31 am ASCENDIS PHARMA A/S: Q2 2024 Earnings Release
03/09/2024 04:35 pm GH RESEARCH PLC: Q2 2024 Earnings Release
28/08/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q2 2024 Earnings Release (Projected)
28/08/2024 AKESO, INC.: Q2 2024 Earnings Release
27/08/2024 06:40 pm KEYMED BIOSCIENCES INC.: Q2 2024 Earnings Release
27/08/2024 BEIGENE, LTD.: Q2 2024 Earnings Release
26/08/2024 HITGEN INC.: Q2 2024 Earnings Release (Projected)
23/08/2024 06:20 am CLARITY PHARMACEUTICALS LTD: Q4 2024 Earnings Release
23/08/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. Calendar BeiGene, Ltd.
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition